NORMAL SITUATION

Apotheek Willebroek

Export PDF

Company — Normal situation.

Financial year 2024 · Closed on 31/12/2024

Net result84,6 k €-44,6 %over 1 year

Gross margin205 k €-53,3 %over 1 year

Equity397,2 k €+27,0 %over 1 year

Workforce3,4 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

Apotheek Willebroek is a company registered in Belgium. It employs on average 3,4 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0436.298.377
Legal form: Private limited company
Contributed capital: 18 600,00 €
Latest accounts: 31/12/2024
Average workforce: 3,4 ETP

Joint committees (2)

313
3130

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 32 filings

Trend over 19 financial years

	2024		2023		2022		2021		2020
Income statement
Gross margin	205 k €	-53.3%	439,1 k €	+17.3%	374,4 k €	+43.7%	260,5 k €	+31.2%	198,6 k €
EBITDA	139,9 k €	-41.8%	240,4 k €	+46.9%	163,6 k €	+4.7%	156,3 k €	+23.3%	126,8 k €
Operating result	121,4 k €	-43.2%	213,7 k €	+58.7%	134,7 k €	+5.4%	127,8 k €	+20.7%	105,9 k €
Net result	84,6 k €	-44.6%	152,7 k €	+58.9%	96,1 k €	+6.7%	90,1 k €	-10.1%	100,3 k €
Balance sheet
Equity	397,2 k €	+27.0%	312,6 k €	+95.5%	159,9 k €	0.0%	159,9 k €	+20.5%	132,8 k €
Total assets	498 k €	-20.0%	622,2 k €	+10.1%	565,1 k €	+2.2%	553,1 k €	+7.4%	515,1 k €
Cash	310,9 k €	+66.4%	186,8 k €	+59.0%	117,5 k €	+20.4%	97,6 k €	+20.7%	80,8 k €
Debts	100,7 k €	-67.4%	309,3 k €	-23.6%	405 k €	+5.0%	385,7 k €	+1.0%	382,1 k €
Other
Workforce	3,4 ETP	0.0%	3,4 ETP	-19.0%	4,2 ETP	+100%	2,1 ETP	+23.5%	1,7 ETP

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 13 ended

Active mandates

Geert Reyniers

Managing director · since 15 avril 2024 · until 13 juin 2030

Active

TM Pharma

Director · since 08 décembre 2016 · until 15 avril 2024 · 0881.130.182

Represented by Carlos Otega Saez

Active

Ended mandates

Apoplus

Director · since 08 décembre 2016 · 0667.565.282

Represented by Carlos Ortega Saez

Ended

Apoplus

Manager · since 08 décembre 2016 · 0667.565.282

Represented by Carlos Ortega Saez

Ended

EUROSAN INTER PRODUCTION

Director · since 01 septembre 2009 · 0444.432.422

Represented by STEFAAN HENDRICKX

Ended

EUROSAN INTER PRODUCTION

Manager · since 01 septembre 2009 · 0444.432.422

Represented by STEFAAN HENDRICKX

Ended

Full financial information

Source · NBB

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	23/06/2025	28/03/2024	20/07/2023	15/07/2022	29/06/2021	19/06/2020
General meeting	12/06/2025	27/03/2024	14/06/2023	08/06/2022	09/06/2021	10/06/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 32 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	12/06/2025	23/06/2025	French	PDF
Abridged model	31/12/2023	27/03/2024	28/03/2024	Dutch	PDF
Abridged model	31/12/2022	14/06/2023	20/07/2023	Dutch	PDF
Abridged model	31/12/2021	08/06/2022	15/07/2022	Dutch	PDF
Abridged model	31/12/2020	09/06/2021	29/06/2021	Dutch	PDF
Abridged model	31/12/2019	10/06/2020	19/06/2020	Dutch	PDF
Abridged model	31/12/2018	12/06/2019	24/06/2019	Dutch	PDF
Abridged model	31/12/2017	13/06/2018	19/06/2018	Dutch	PDF
Abridged model	31/12/2016	14/06/2017	13/07/2017	Dutch	PDF
Abridged model	31/12/2015	08/06/2016	30/06/2016	Dutch	PDF
Abridged model	31/12/2014	10/06/2015	06/08/2015	Dutch	PDF
Abridged model	31/12/2013	11/06/2014	26/08/2014	Dutch	PDF
Abridged model	31/12/2012	12/06/2013	12/07/2013	Dutch	PDF
Abridged model	31/12/2011	13/06/2012	21/08/2012	Dutch	PDF
Abridged model	31/12/2010	08/06/2011	14/07/2011	Dutch	PDF
Abridged model	31/12/2009	09/06/2010	20/07/2010	Dutch	PDF
Abridged model	31/12/2008	30/06/2009	23/07/2009	Dutch	PDF
Abridged model	31/12/2007	11/06/2008	31/07/2008	Dutch	PDF
Abridged model	31/12/2006	13/06/2007	30/07/2007	Dutch	PDF
Abridged model	31/12/2005	30/06/2006	17/07/2006	Dutch	PDF
Abridged model	31/12/2004	30/06/2005	06/07/2005	Dutch	PDF
Abridged model	31/12/2003	30/06/2004	03/12/2004	Dutch	PDF
Abridged model	31/12/2002	27/05/2003	30/09/2003	Dutch	PDF
Abridged model	31/12/2001	14/05/2002	08/07/2002	Dutch	PDF

View all 32 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 13 ended

Active mandates

Geert Reyniers

Managing director · since 15 avril 2024 · until 13 juin 2030

Active

TM Pharma

Director · since 08 décembre 2016 · until 15 avril 2024 · 0881.130.182

Represented by Carlos Otega Saez

Active

Ended mandates

Apoplus

Director · since 08 décembre 2016 · 0667.565.282

Represented by Carlos Ortega Saez

Ended

Apoplus

Manager · since 08 décembre 2016 · 0667.565.282

Represented by Carlos Ortega Saez

Ended

EUROSAN INTER PRODUCTION

Director · since 01 septembre 2009 · 0444.432.422

Represented by STEFAAN HENDRICKX

Ended

EUROSAN INTER PRODUCTION

Manager · since 01 septembre 2009 · 0444.432.422

Represented by STEFAAN HENDRICKX

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Dissolution28/05/2025
RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring11/03/2025
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates13/02/2025
ONTSLAGEN - BENOEMINGEN
PDF
Registered office04/07/2024
MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates07/05/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DIVERSEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Registered office22/03/2018
MAATSCHAPPELIJKE ZETEL
PDF
Mandates31/01/2017
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2024
Annual accounts 202484,6 k €↓
2024
Name changeAPOTHEEK WILLEBROEK
2023
Annual accounts 2023152,7 k €↑
2022
Annual accounts 202296,1 k €↑
2021
Annual accounts 202190,1 k €↓
2021
Name changeKollni
2020
Annual accounts 2020100,3 k €↑
2019
Annual accounts 201927,3 k €↑
2018
Annual accounts 2018-61,3 k €↓
2017
Annual accounts 2017-1 k €↓
2016
Annual accounts 201626,6 k €↑
2015
Annual accounts 201523,2 k €↓
2014
Annual accounts 201423,9 k €↑
2013
Annual accounts 20137,4 k €↓
2012
Annual accounts 201219,4 k €↑
2011
Annual accounts 201111,7 k €↓
2010
Annual accounts 201018,9 k €↓
2009
Annual accounts 200926,1 k €↑
2008
Annual accounts 200822,7 k €↑
2007
Annual accounts 200720,7 k €↑
2006
Annual accounts 20062,9 k €

Apotheek Willebroek

Overview

Identity

Financials

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline